December 16 (SeeNews) - Bulgarian drug trader Sopharma Trading [BUL:SO5], a unit of drug maker Sopharma, has signed two drug supply contracts worth a total of 6.2 million levs ($3.5 million/3.2 million euro), public procurement agency data, published on Monday, shows.
The larger contract, worth 3.9 million levs, was signed with Burgas-based Complex Oncology Centre, while the other deal, worth 2.3 million levs, was signed with Sofia-based ISUL hospital, according to public procurement agency data.
The deal with Complex Oncology Centre was signed on November 21, while the other contract was inked on December 2.
Twelve companies tabled bids in the procedure for awarding the larger contract, while the other procedure drew ten bids.
As at 12:05 CET on Monday, Sopharma Trading shares traded 2.61% lower at 5.6 levs on the Bulgarian Stock Exchange.
(1 euro = 1.95583 levs)